The Twelfth Five-Year Plan for the Chinese Medicine Industry is expected to be introduced at the end of the month

Recently, the reporter learned that the Twelfth Five-Year Plan of the Chinese Medicine Industry was soon to be announced. According to Wang Xuegong, the Division of Medicines of the Consumer Products Division of the Ministry of Industry and Information Technology, the "12th Five-Year Plan" ("Planning") of the "Pharmaceutical Industry", which was led by the Ministry of Industry and Information Technology and is expected by the industry for nearly two years, is currently in print and is expected to be released at the end of this month.

According to Wang Xuegong, the upcoming "Planning" will take the transformation of development as the main line, with structural adjustment and transformation and upgrading as the main directions, and strengthen the core competitiveness and sustainability of the industry by strengthening independent innovation, transforming and upgrading traditional medicine and other means. We will develop our capabilities and accelerate the establishment of a drug supply guarantee system based on the national essential drug system. We will continue to meet the growing health needs of the people and promote the transformation of China's pharmaceutical industry from big to strong.

It is reported that the Twelfth Five-Year Plan of the Chinese Medicine Industry will focus on supporting the industrialization of innovative drug varieties for the treatment of common diseases and major diseases, the construction of high-quality raw material medicine production bases, and the comprehensive demonstration applications of advanced technologies for the quality control of traditional Chinese medicine pharmaceutical processes. "It is expected that by 2015, the output value of the Chinese medicine industry will exceed one trillion yuan," said Fang Shuting, president of the Chinese Medicine Association.